obesity

Analysts Objectivity in Coverage of the Obesity Space
Motley Fool
Sun, 10/28/12 - 11:43 am
obesity
weight loss
Orexigen
Arena Pharmaceuticals
A Looming Threat for Arena and VIVUS
Motley Fool
Sun, 10/28/12 - 11:41 am
Arena Pharmaceuticals
Vivus
Orexigen
weight loss
obesity
Analysts Objectivity in Coverage of the Obesity Space
Motley Fool
Fri, 10/26/12 - 10:33 am
obesity
Arena Pharmaceuticals
Orexigen
Vivus
FDA Lightens Up on Obesity Drugs
Motley Fool
Mon, 10/22/12 - 06:12 pm
FDA
obesity
Contrave
Arena Pharmaceuticals
Vivus
Orexigen
What Does This Rejection Mean for Obesity Drugmakers?
Motley Fool
Sat, 10/20/12 - 10:36 am
Vivus
Qsymia
obesity
weight loss
Belviq
Arena Pharmaceuticals
Eisai’s Epilepsy Drug Helps Obese Patients Reduce Weight
Bloomberg
Wed, 10/17/12 - 11:20 am
Eisai
epilepsy
obesity
Zonegran
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
Vivus’s Weight-Loss Pill Covered by Insurers 30% of the Time
Bloomberg
Mon, 10/1/12 - 12:31 pm
Vivus
insurance
obesity
Qsymia
Arena: DEA Schedule IV Will Make Belviq The Obesity Blockbuster Drug
Seeking Alpha
Tue, 09/25/12 - 04:01 pm
Arena Pharmaceuticals
Belviq
obesity
Obesity In America Likely To Set Up Arena And Vivus For Big Gains
TheStreet.com
Tue, 09/25/12 - 12:37 pm
Arena Pharmaceuticals
Vivus
obesity
Qsymia
Belviq
With Arena, Patience Is A Virtue
Seeking Alpha
Mon, 09/24/12 - 05:59 pm
Arena Pharmaceuticals
Belviq
obesity
Science Arena Investors Need to Know
Motley Fool
Sat, 09/22/12 - 02:19 pm
Arena
weight loss
obesity
Belviq
EU Approval? Fat Chance!
Motley Fool
Sat, 09/22/12 - 02:15 pm
Vivus
obesity
weight loss
Qsymia
Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe
Forbes
Fri, 09/21/12 - 01:00 pm
Vivus
Europe
Qsiva
Qsymia
obesity
2 Big Events For Obesity Drugmakers
Motley Fool
Thu, 09/20/12 - 11:10 am
obesity
Arena Pharmaceuticals
Vivus
Qsymia
Belviq
Obesity Drugs Gain Attention on FDA Backing for Therapies
Bloomberg
Wed, 09/19/12 - 10:53 am
FDA
obesity
Zafgen
beloranib
Arena Pharmaceuticals
[video] Fatter Profits for Drug Makers Ahead?
CNBC
Tue, 09/18/12 - 04:43 pm
obesity
Arena Pharmaceuticals
Orexigen
Vivus
Vivus Quietly Notes In 8-k That Qsymia Is Now Commercially Available
Yahoo/Reuters
Mon, 09/17/12 - 10:13 am
Qsymia
obesity
Vivus
Topiramate
J&J
Biotechnology News: IntraPace's New Drug Stops You From Excessive Eating
Minyanville
Sat, 09/15/12 - 09:39 am
IntraPace
Abiliti
weight loss
obesity
IntraPace preps anti-obesity device for U.S. regulatory path
Wed, 09/12/12 - 10:24 pm
obesity
IntraPace
Abilti

Pages